Impact of the pneumococcal 10-valent vaccine on reducing hospitalization for community-acquired pneumonia in children
Abstract Objective: To describe and analyze the occurrence of hospitalizations for community-acquired pneumonia in children before and after the pneumococcal 10-valent conjugate vaccine implementation into the National Immunization Program. Methods: This is an ecological study that includes records...
Saved in:
Main Authors: | Sandra Rodrigues da Silva (Author), Luane Marques de Mello (Author), Anderson Soares da Silva (Author), Altacílio Aparecido Nunes (Author) |
---|---|
Format: | Book |
Published: |
Sociedade de Pediatria de São Paulo.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical and epidemiological characteristics of severe community-acquired pneumonia in children after introduction of the 10-valent pneumococcal vaccine
by: Lima EJF, et al.
Published: (2015) -
Cost-effectiveness analysis of replacing the 10-valent pneumococcal conjugate vaccine (PCV10) with the 13-valent pneumococcal conjugate vaccine (PCV13) in Brazil infants
by: Johnna Perdrizet, et al.
Published: (2021) -
Distribution of 13-Valent pneumococcal conjugate vaccine serotype streptococcus pneumoniae in adults 50 Years and Older presenting with community-acquired pneumonia in Israel
by: Gili Regev-Yochay, et al.
Published: (2018) -
Modeling the sustained use of the 13-valent pneumococcal conjugate vaccine compared to switching to the 10-valent vaccine in Mexico
by: Matthew Wasserman, et al.
Published: (2019) -
The effectiveness of 13-valent pneumococcal vaccine against community acquired pneumonia in young children: a systematic review and meta-analysis
by: Ninel Revenco, et al.
Published: (2022)